SEC Filing Details

Document Details

Form
Filing Date
11-03-2023
Document Date
11-01-2023
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Taysha Gene Therapies
Issuer
TAYSHA GENE THERAPIES, INC.
Scroll to top